Elucidation of biological and therapeutic potential: an integrated in silico and in vitro investigations of N-hydroxy-2-(naphthalen-1-yl)acetamide ligand and its zinc(II) complex
摘要
Addressing the critical need for novel antimicrobial and therapeutic agents, and recognizing the established biological significance of hydroxamic acids, this study focuses on the strategic synthesis of a bioactive molecule and its corresponding metal-complex to precisely modulate their properties for targeted biological activity. In the light of this, mononuclear homoleptic Zn(II) complex [Zn(1-NaphAcH)2] (where 1-NaphAcHK = potassium 1-naphthaleneacetohydroxamate; potassium N-hydroxy-2-(naphthalen-1-yl)acetamide; C11H9CONHOK) (KHL) was synthesized. Physicochemical characterization (elemental analysis, molar conductivity measurements) and spectroscopic techniques (FTIR, UV-visible, 1H and 13C NMR), Powder X-ray diffraction and Mass spectrometry were studied to characterize the complex exhibiting a distorted tetrahedral geometry with O,O-coordination via carbonyl and hydroxamic oxygen atoms. Computational analysis confirmed its superior stability compared to the free ligand, with further analysis performed via quantum chemical calculations. The complex demonstrated enhanced antimicrobial activity against selected bacteria and fungi compared to standard drugs. Cytotoxicity was evaluated on L20B and rhabdomyosarcoma cell lines. To further corroborate the in vitro studies, molecular docking studies on bacterial protein Salmonella typhi LuxS (PDB ID: 5V2W) revealed favorable binding energy and a high docking score for the ligand, suggesting its potential as a therapeutic agent.
Graphical abstractA novel Zn(II) hydroxamate complex with distorted tetrahedral geometry was synthesized and characterized. DFT confirmed superior stability and reduced polarity, rationalizing the enhanced antimicrobial and cytotoxic profiles via improved lipophilicity (Overtone’s concept). Molecular docking revealed strong binding to S. typhi LuxS, indicating therapeutic potential.